JP2008163006A - Skin cosmetic - Google Patents
Skin cosmetic Download PDFInfo
- Publication number
- JP2008163006A JP2008163006A JP2007301421A JP2007301421A JP2008163006A JP 2008163006 A JP2008163006 A JP 2008163006A JP 2007301421 A JP2007301421 A JP 2007301421A JP 2007301421 A JP2007301421 A JP 2007301421A JP 2008163006 A JP2008163006 A JP 2008163006A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- acid
- hyaluronic acid
- weight
- collagen peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 40
- -1 hyaluronic acid oligosaccharide Chemical class 0.000 claims abstract description 69
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 39
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 39
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 30
- 102000008186 Collagen Human genes 0.000 claims abstract description 28
- 108010035532 Collagen Proteins 0.000 claims abstract description 28
- 229920001436 collagen Polymers 0.000 claims abstract description 28
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 21
- 229940031723 1,2-octanediol Drugs 0.000 claims abstract description 9
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 22
- 235000000346 sugar Nutrition 0.000 abstract description 12
- 150000008163 sugars Chemical class 0.000 abstract description 9
- 230000009759 skin aging Effects 0.000 abstract description 8
- 230000008591 skin barrier function Effects 0.000 abstract description 6
- 125000000539 amino acid group Chemical group 0.000 abstract description 3
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 abstract description 3
- 239000000470 constituent Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000006096 absorbing agent Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000242583 Scyphozoa Species 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 239000002280 amphoteric surfactant Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000251468 Actinopterygii Species 0.000 description 5
- 235000019688 fish Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000005194 fractionation Methods 0.000 description 5
- 229960002449 glycine Drugs 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940092738 beeswax Drugs 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000005068 transpiration Effects 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 2
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- FCKYPQBAHLOOJQ-UHFFFAOYSA-N Cyclohexane-1,2-diaminetetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)C1CCCCC1N(CC(O)=O)CC(O)=O FCKYPQBAHLOOJQ-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 229940009662 edetate Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229940014041 hyaluronate Drugs 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 229940056211 paraffin Drugs 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- XUYJLQHKOGNDPB-UHFFFAOYSA-N phosphonoacetic acid Chemical compound OC(=O)CP(O)(O)=O XUYJLQHKOGNDPB-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- LBPHBRVNBKGYTP-UHFFFAOYSA-N (1-hydroxy-1-phosphonohexyl)phosphonic acid Chemical compound CCCCCC(O)(P(O)(O)=O)P(O)(O)=O LBPHBRVNBKGYTP-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RNNHLXAEVKCLDG-UHFFFAOYSA-N 2,2,4,4,6,6,8,8-octamethyl-1,3,5,7,9,2,4,6,8,10-pentaoxapentasilecane Chemical compound C[Si]1(C)O[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 RNNHLXAEVKCLDG-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- RAEOEMDZDMCHJA-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-[2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl]amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CCN(CC(O)=O)CC(O)=O)CC(O)=O RAEOEMDZDMCHJA-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- DMBTYPPQYTYHFZ-UHFFFAOYSA-N 2-hydroxybenzoic acid methyl 2-hydroxybenzoate Chemical compound OC(=O)C1=CC=CC=C1O.COC(=O)C1=CC=CC=C1O DMBTYPPQYTYHFZ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KWYJDIUEHHCHCZ-UHFFFAOYSA-N 3-[2-[bis(2-carboxyethyl)amino]ethyl-(2-carboxyethyl)amino]propanoic acid Chemical compound OC(=O)CCN(CCC(O)=O)CCN(CCC(O)=O)CCC(O)=O KWYJDIUEHHCHCZ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000962514 Alosa chrysochloris Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000242567 Aurelia aurita Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241000272185 Falco Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 241000269908 Platichthys flesus Species 0.000 description 1
- 241000269980 Pleuronectidae Species 0.000 description 1
- 241000269978 Pleuronectiformes Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- IFQUWYZCAGRUJN-UHFFFAOYSA-N ethylenediaminediacetic acid Chemical compound OC(=O)CNCCNCC(O)=O IFQUWYZCAGRUJN-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical class OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- GCXZDAKFJKCPGK-UHFFFAOYSA-N heptane-1,2-diol Chemical compound CCCCCC(O)CO GCXZDAKFJKCPGK-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical class OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- LJZULWUXNKDPCG-UHFFFAOYSA-N nonane-1,2-diol Chemical compound CCCCCCCC(O)CO LJZULWUXNKDPCG-UHFFFAOYSA-N 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 1
- 229940039790 sodium oxalate Drugs 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚化粧料に関する。詳しくは、皮膚老化防止効果に優れる皮膚化粧料に関する。 The present invention relates to a skin cosmetic. Specifically, the present invention relates to a skin cosmetic that is excellent in the effect of preventing skin aging.
老化皮膚は、乾燥して滑らかさのない荒れた肌状態であり、その改善には、皮膚に適度な水分と油分を与える必要がある。そのため、皮膚化粧料には、従来から親水性の皮膚保湿剤と油性の皮膚柔軟剤とが用いられてきた。しかしながら、グリセリンやプロピレングリコール等の親水性の皮膚保湿剤では、角質層の水分を吸収して却って皮膚水分を損失する原因となることがあった。また、流動パラフィンやワセリン等の油性の皮膚柔軟剤では、表皮からの水分蒸散を充分に抑制できる量を配合すると、べたつき感が生じるうえ、皮膚の正常な新陳代謝を阻害する原因となることもあった。 Aging skin is a dry, rough and rough skin condition, and in order to improve it, it is necessary to give the skin appropriate moisture and oil. For this reason, hydrophilic skin moisturizers and oily skin softeners have been used for skin cosmetics. However, hydrophilic skin moisturizers such as glycerin and propylene glycol sometimes absorb the moisture in the stratum corneum and cause loss of skin moisture. In addition, oily emollients such as liquid paraffin and petrolatum, when added in an amount that sufficiently suppresses the transpiration of water from the epidermis, may cause stickiness and may inhibit normal skin metabolism. It was.
そこで、セラミド類と平均分子量が10万〜500万のヒアルロン酸等の酸性ムコ多糖類を配合した皮膚化粧料(特許文献1参照)、分子量100万以上の高分子量ヒアルロン酸、分子量10万以下の低分子量ヒアルロン酸、多価アルコールおよびエデト酸塩とを含有した皮膚化粧料(特許文献2参照)、フィトステロール、ヒアルロン酸またはセラミド類を配合した皮膚化粧料(特許文献3参照)、γ−アミノ−β−ヒドロキシ酪酸とコラーゲンを含有した皮膚老化防止化粧料(特許文献4参照)などが提案されている。しかしながら、これら試みに拠って、皮膚老化防止効果はある程度は改善することができるものの、未だ満足のいくものではない。 Therefore, skin cosmetics (see Patent Document 1) containing ceramides and acidic mucopolysaccharides such as hyaluronic acid having an average molecular weight of 100,000 to 5,000,000, high molecular weight hyaluronic acid having a molecular weight of 1 million or more, molecular weight of 100,000 or less Skin cosmetics containing low molecular weight hyaluronic acid, polyhydric alcohol and edetate (see Patent Document 2), skin cosmetics containing phytosterol, hyaluronic acid or ceramides (see Patent Document 3), γ-amino- Skin anti-aging cosmetics containing β-hydroxybutyric acid and collagen (see Patent Document 4) have been proposed. However, although these effects can improve skin aging prevention effects to some extent, they are still not satisfactory.
本発明は、前記従来技術に鑑みてなされたものであって、皮膚の水分保持機能を亢進することにより乾燥皮膚を改善して荒れ肌や皮膚のバリア効果を改善するという、皮膚老化防止効果に優れる皮膚化粧料を提供することを課題とする。 The present invention has been made in view of the above-described prior art, and has an excellent skin aging prevention effect of improving dry skin and improving rough skin and skin barrier effect by enhancing the moisture retention function of the skin. It is an object to provide a skin cosmetic.
すなわち、本発明は、
〔1〕ヒアルロン酸オリゴ糖及び/又はその塩と、炭素数5〜10の1,2−アルカンジオールとを含有してなる皮膚化粧料、
〔2〕前記ヒアルロン酸オリゴ糖が、6糖以下のヒアルロン酸オリゴ糖であることを特徴とする前記〔1〕に記載の皮膚化粧料、
〔3〕下記式(1)
〔4〕前記コラーゲンペプチドの分子量が、重量平均分子量で100〜3000であることを特徴とする前記〔3〕に記載の皮膚化粧料、並びに
〔5〕1,2−アルカンジオールが、1,2−オクタンジオールであることを特徴とする前記〔1〕〜〔4〕のいずれかに記載の皮膚化粧料
に関する。
That is, the present invention
[1] A skin cosmetic comprising hyaluronic acid oligosaccharide and / or a salt thereof and a 1,2-alkanediol having 5 to 10 carbon atoms,
[2] The skin cosmetic according to [1], wherein the hyaluronic acid oligosaccharide is a hexasaccharide or less hyaluronic acid oligosaccharide,
[3] The following formula (1)
[4] The skin cosmetic according to [3] above, wherein the molecular weight of the collagen peptide is 100 to 3000 in weight average molecular weight, and [5] 1,2-alkanediol is 1,2 -Octanediol It is related with the skin cosmetics in any one of said [1]-[4] characterized by the above-mentioned.
本発明の皮膚化粧料は、皮膚の水分保持機能を亢進することにより乾燥皮膚を改善して荒れ肌や皮膚のバリア効果を改善するという、皮膚老化防止効果を奏する。 The skin cosmetic of the present invention has the effect of preventing skin aging, which improves dry skin by enhancing the moisture retention function of the skin, thereby improving rough skin and the skin barrier effect.
本発明の皮膚化粧料には、ヒアルロン酸オリゴ糖及び/又はその塩と、1,2−アルカンジオールとを含有する。 The skin cosmetic of the present invention contains hyaluronic acid oligosaccharide and / or a salt thereof and 1,2-alkanediol.
本発明で用いられるヒアルロン酸オリゴ糖は、化粧料に使用できるものであれば特に限定されないが、皮膚老化防止効果に優れることから、ヒアルロン酸の基本単位が10単位以下、すなわち20糖以下のヒアルロン酸オリゴ糖を用いるのが好ましく、ヒアルロン酸の基本単位が5単位以下(すなわち、10糖以下)からなるヒアルロン酸オリゴ糖を用いるのがより好ましい。なかでも、ヒアルロン酸の基本単位が3単位以下(すなわち、6糖以下)のヒアルロン酸オリゴ糖を用いるのが更に好ましく、基本単位が2単位以下(すなわち、4糖以下)のヒアルロン酸オリゴ糖を用いるのが特に好ましい。尚、ヒアルロン酸の基本単位とは、D−グルクロン酸とN−アセチル−D−グルコサミンとがグリコシド結合した2糖を表す。 The hyaluronic acid oligosaccharide used in the present invention is not particularly limited as long as it can be used in cosmetics. However, since hyaluronic acid has an excellent effect of preventing skin aging, hyaluronic acid having a basic unit of 10 units or less, that is, 20 sugars or less. It is preferable to use an acid oligosaccharide, and it is more preferable to use a hyaluronic acid oligosaccharide having a basic unit of hyaluronic acid of 5 units or less (that is, 10 sugars or less). Among them, it is more preferable to use a hyaluronic acid oligosaccharide having a basic unit of hyaluronic acid of 3 units or less (that is, 6 sugars or less). It is particularly preferable to use it. The basic unit of hyaluronic acid represents a disaccharide in which D-glucuronic acid and N-acetyl-D-glucosamine are glycosidically bonded.
ヒアルロン酸オリゴ糖は、種々の既知の方法で得ることができる。例えば、市販の高分子量のヒアルロン酸を酵素分解、酸分解、塩基分解、加熱処理、超音波処理などの分解処理により製造することができる。また、化学合成により製造しても良い。 Hyaluronic acid oligosaccharides can be obtained by various known methods. For example, commercially available high molecular weight hyaluronic acid can be produced by enzymatic decomposition, acid decomposition, base decomposition, heat treatment, ultrasonic treatment or the like. Moreover, you may manufacture by chemical synthesis.
たとえば、酵素分解の方法によりヒアルロン酸オリゴ糖を製造する場合、国際公開第2002/4471号パンフレットや、Glycobiology,2002年,第12巻,第7号,第421−426頁に開示される方法に準じて製造することができる。すなわち、高分子量ヒアルロン酸塩を、例えば、溶液のpHが5付近になるように緩衝液(例えば、0.1Mリン酸緩衝液)に溶解し、ヒアルロニダーゼを添加して加水分解する。加水分解の温度は、37℃付近が好ましく、1〜24時間程度、好ましくは、5〜15時間程度反応させれる。反応後、10,000rpm程度で遠心分離して上清を回収し、この上清をイオン交換カラムなどにより分画することにより得ることができる。 For example, when hyaluronic acid oligosaccharides are produced by an enzymatic degradation method, the methods disclosed in International Publication No. 2002/4471 pamphlet and Glycobiology, 2002, Vol. 12, No. 7, pages 421-426 are used. It can be manufactured similarly. That is, high molecular weight hyaluronate is dissolved in a buffer solution (for example, 0.1 M phosphate buffer solution) so that the pH of the solution is around 5, and then hydrolyzed by adding hyaluronidase. The hydrolysis temperature is preferably around 37 ° C., and is allowed to react for about 1 to 24 hours, preferably about 5 to 15 hours. After the reaction, the supernatant can be recovered by centrifugation at about 10,000 rpm, and the supernatant can be obtained by fractionation using an ion exchange column or the like.
酸加水分解によりヒアルロン酸オリゴ糖を製造する場合、高分子量ヒアルロン酸塩を、たとえば、濃塩酸の50%水溶液中、40℃〜還流温度で1〜5時間程度反応させたのち、イオン交換カラムなどにより分画することにより得ることができる。また、DMSO等の溶媒中に0.05〜1M程度の塩酸を用いて加熱する、より緩和な条件下で加水分解することもできる。 When producing hyaluronic acid oligosaccharides by acid hydrolysis, for example, after reacting high molecular weight hyaluronate in a 50% aqueous solution of concentrated hydrochloric acid at 40 ° C. to reflux temperature for about 1 to 5 hours, an ion exchange column, etc. Can be obtained by fractionation. Moreover, it can also hydrolyze on the milder conditions heated using about 0.05-1M hydrochloric acid in solvents, such as DMSO.
なお、ヒアルロン酸オリゴ糖の塩としては、ナトリウム塩、カリウム塩、トリエタノールアミン塩などが例示されるが、ナトリウム塩が好ましく用いられる。 Examples of the hyaluronic acid oligosaccharide salt include sodium salt, potassium salt, triethanolamine salt and the like, but sodium salt is preferably used.
ヒアルロン酸オリゴ糖及び/又はその塩の含有量は、本発明の効果を発揮すれば特に限定はなく、所望の効果を発揮させる観点から、化粧料中、0.01重量%以上が好ましく、より好ましくは0.1重量%以上である。また、使用感が良好なことから、化粧料中、10重量%以下が好ましく、より好ましくは5重量%以下である。これらから、皮膚化粧料中の含有量は、0.01〜10重量%が好ましく、0.1〜5重量%がより好ましい。 The content of the hyaluronic acid oligosaccharide and / or salt thereof is not particularly limited as long as the effect of the present invention is exhibited, and is preferably 0.01% by weight or more in the cosmetic from the viewpoint of exerting the desired effect. Preferably it is 0.1 weight% or more. Further, in terms of good usability, the content in the cosmetic is preferably 10% by weight or less, more preferably 5% by weight or less. From these, 0.01-10 weight% is preferable and, as for content in skin cosmetics, 0.1-5 weight% is more preferable.
本発明で用いられる1,2−アルカンジオールとしては、炭素数5〜10の1,2−アルカンジオールが用いられる。具体的には、1,2−ペンタンジオール、1,2−ヘキサンジオール、1,2−ヘプタンジオール、1,2−オクタンジオール、1,2−ノナンジオール、1,2−デカンジオールが挙げられ、これらのうち、1,2−オクタンジオールを用いるのが好ましい。尚、本発明においては、これらの1種を単独で、或いは2種以上を適宜組み合わせて用いることもできる。 As the 1,2-alkanediol used in the present invention, 1,2-alkanediol having 5 to 10 carbon atoms is used. Specific examples include 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol, and 1,2-decanediol. Of these, it is preferable to use 1,2-octanediol. In the present invention, one of these may be used alone, or two or more may be used in appropriate combination.
1,2−アルカンジオールの含有量は、本発明の効果を発揮すれば特に限定はなく、所望の効果を発揮させる観点から、化粧料中、0.05重量%以上が好ましく、より好ましくは0.1重量%以上である。また、使用感が良好なことから、化粧料中、10重量%以下が好ましく、より好ましくは5重量%以下である。これらから、皮膚化粧料中の含有量は、0.05〜10重量%が好ましく、0.1〜5重量%がより好ましい。 The content of 1,2-alkanediol is not particularly limited as long as the effects of the present invention are exhibited. From the viewpoint of exerting the desired effects, the content is preferably 0.05% by weight or more, more preferably 0. .1% by weight or more. Further, in terms of good usability, the content in the cosmetic is preferably 10% by weight or less, more preferably 5% by weight or less. From these, 0.05-10 weight% is preferable and, as for content in skin cosmetics, 0.1-5 weight% is more preferable.
本発明においては、皮膚老化防止効果をより向上させるためにコラーゲンペプチドを含有することができる。コラーゲンペプチドとは、Gly−X−Y(式中、Glyはグリシン残基を表し、X,Yは互いに同一または異なってもよいアミノ酸残基を表す。)で示されるコラーゲントリペプチドを構成単位とし、下記式(1)
コラーゲンペプチドの原料となるコラーゲンの起源は、特に限定されず、獣、魚類、貝類、クラゲ類、海綿類などを挙げることができる。 The origin of the collagen used as the raw material for the collagen peptide is not particularly limited, and examples thereof include animals, fish, shellfish, jellyfish, and sponges.
具体的には、牛、豚などの獣;ヒラメ、カレイ、カツオ、サメ、エイ、サバ、サンマ、アジ、イワシ、サケ、テラピア、マグロ、タラ、オヒョウなどの魚類;ムラサキイガイ、アコヤガイ、ホタテガイ、ウグイスガイ、カキなどの貝類;ミズクラゲ、タコクラゲ、アカクラゲ、ヒゼンクラゲ、ビゼンクラゲ、キタユウレイクラゲ、エチゼンクラゲなどのクラゲ類;尋常海綿綱、石灰海綿綱、硬骨海綿綱、六放海綿綱などの海綿類などを例示することができる。 Specifically, beef such as cattle and pigs; flounder, flatfish, skipjack, shark, ray, mackerel, saury, horse mackerel, sardine, salmon, tilapia, tuna, cod, halibut and other fish; mussel, pearl oyster, scallop, warbler Examples include shellfish such as oysters, oysters; jellyfishes such as moon jellyfish, octopus jellyfish, red jellyfish, jellyfish jellyfish, bizen jellyfish, northern jellyfish, echidella jellyfish; sponges such as common sponge, lime sponge, bone-bone sponge, and six-band sponge can do.
コラーゲンの抽出は特に限定されず、公知の方法により行うことができる。例えば、魚皮、魚骨、魚鱗などを細断し、エタノール、水、塩化ナトリウム溶液などにより抽出して得ることができる。 Extraction of collagen is not particularly limited, and can be performed by a known method. For example, it can be obtained by chopping fish skin, fish bones, fish scales and the like and extracting them with ethanol, water, sodium chloride solution or the like.
そして、コラーゲンペプチドは、コラーゲンにコラゲナーゼを作用させて調製することができる。コラーゲンペプチドの調製方法は特に限定されず、公知の方法により行うことができる。例えば、固定化担体に固定化されたコラゲナーゼを、バッチ法、カラム法又はこれらの組合せにより、反応温度40〜45℃に設定して製造することができる。このとき用いるコラゲナーゼは、コラーゲン特有のアミノ酸配列〔Gly−X−Y(式中、Glyはグリシン残基を表し、X,Yは互いに同一または異なってもよいアミノ酸残基を表す。)〕のグリシン残基のアミノ基末端側を特異的に切断するコラゲナーゼを用いるのが好ましい。 The collagen peptide can be prepared by allowing collagenase to act on collagen. The method for preparing the collagen peptide is not particularly limited, and can be performed by a known method. For example, collagenase immobilized on an immobilization carrier can be produced at a reaction temperature of 40 to 45 ° C. by a batch method, a column method, or a combination thereof. The collagenase used at this time is a glycine having an amino acid sequence unique to collagen [Gly-XY (where Gly represents a glycine residue, and X and Y represent amino acid residues which may be the same or different from each other)]. It is preferable to use a collagenase that specifically cleaves the amino terminal side of the residue.
特定の平均分子量のコラーゲンペプチドとするには、公知の分取方法により分画すればよい。例えば、ゲル濾過法やクロマトグラフィーなどにより分画することができる。 In order to obtain a collagen peptide having a specific average molecular weight, fractionation may be performed by a known fractionation method. For example, fractionation can be performed by gel filtration or chromatography.
尚、コラーゲンペプチドは、市販品をそのまま利用することもできる。本発明で用い得る市販品としては、例えば、商品名 コラーゲン・トリペプチド(宮城化学工業社製)、商品名 コラーゲン・トリペプチド(井原水産社製)、商品名 ファルコニクスCTP(BG)(一丸ファルコス社製)などが挙げられる。 In addition, the collagen peptide can also utilize a commercial item as it is. Commercially available products that can be used in the present invention include, for example, trade name collagen tripeptide (manufactured by Miyagi Chemical Co., Ltd.), trade name collagen tripeptide (manufactured by Ihara Suisan Co., Ltd.), trade name Falconics CTP (BG) (Ichimaru Falcos) Etc.).
コラーゲンペプチドの含有量は、本発明の効果を発揮すれば特に限定はなく、所望の効果を発揮させる観点から、化粧料中、0.01重量%以上が好ましく、より好ましくは0.1重量%以上である。また、使用感が良好なことから、化粧料中、10重量%以下が好ましく、より好ましくは5重量%以下である。これらから、皮膚化粧料中の含有量は、0.01〜10重量%が好ましく、0.1〜5重量%がより好ましい。 The content of the collagen peptide is not particularly limited as long as the effects of the present invention are exhibited. From the viewpoint of exhibiting the desired effects, the content in the cosmetic is preferably 0.01% by weight or more, more preferably 0.1% by weight. That's it. Further, in terms of good usability, the content in the cosmetic is preferably 10% by weight or less, more preferably 5% by weight or less. From these, 0.01-10 weight% is preferable and, as for content in skin cosmetics, 0.1-5 weight% is more preferable.
本発明の皮膚化粧料には、本発明の効果を損なわない範囲内であれば、上記した成分の他、化粧品や医薬部外品に通常用いられる成分を適宜任意に配合することができる。例えば、油脂、ロウ類、炭化水素、シリコーン類、脂肪酸エステル、高級アルコール、高級脂肪酸等の油性成分;非イオン界面活性剤、陰イオン界面活性剤、陽イオン界面活性剤、両性界面活性剤の各種界面活性剤;低級アルコール、多価アルコール、糖類、ステロール類等のアルコール類;粘度鉱物、水溶性多糖類等の増粘性高分子;紫外線吸収剤;保湿剤;酸化防止剤;金属イオン封鎖剤;被膜形成性高分子化合物、無機顔料、粉体、色素、顔料、染料、ビタミン類、アミノ酸類、収斂剤、美白剤、動植物抽出物、酸、アルカリ等の添加成分;水等を例示することができる。 In the skin cosmetic of the present invention, as long as it does not impair the effects of the present invention, in addition to the above-described components, components usually used in cosmetics and quasi-drugs can be arbitrarily arbitrarily blended. For example, oily components such as fats and oils, waxes, hydrocarbons, silicones, fatty acid esters, higher alcohols, higher fatty acids, etc .; various types of nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants Surfactants; alcohols such as lower alcohols, polyhydric alcohols, saccharides and sterols; thickening polymers such as viscosity minerals and water-soluble polysaccharides; ultraviolet absorbers; humectants; antioxidants; sequestering agents; Examples include film forming polymer compounds, inorganic pigments, powders, pigments, pigments, dyes, vitamins, amino acids, astringents, whitening agents, animal and plant extracts, acids, alkalis, and the like; water and the like. it can.
具体的には、油性成分としては、例えば、オリーブ油、ツバキ油、マカデミアナッツ油、アボカド油等の油脂;カルナバロウ、キャンデリラロウ、ホホバ油、ミツロウ、ラノリン等のロウ類;流動パラフィン、パラフィン、ワセリン、セレシン、マイクロクリスタリンワックス、スクワレン、スクワラン等の炭化水素;メチルポリシロキサン、メチルフェニルポリシロキサン、メチルシクロポリシロキサン、オクタメチルシクロテトラシロキサン、オクタメチルシクロペンタシロキサン、デカメチルシクロペンタシロキサン、メチルハイドロジェンポリシロキサン等のシリコーン類;ミリスチン酸イソプロピル、ミリスチン酸2−オクチルドデシル、2−エチルヘキサン酸セチル、パルミチン酸2−エチルヘキシル、ジ−2−エチルヘキサン酸ネオペンチルグリコール、トリ−2−エチルヘキサン酸グリセロール、オレイン酸2−オクチルドデシル、トリイソステアリン酸グリセロール、トリ−2−エチルヘキサン酸グリセロール、オレイン酸2−オクチルドデシル、リンゴ酸ジイソステアリル、トリイソステアリン酸グリセロール、2−エチルヘキサン酸ジグリセリド等の脂肪酸エステル;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、2−オクチルドデカノール、オレイルアルコール等の高級アルコール類;ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、イソステアリン酸、オレイン酸等の高級脂肪酸が挙げられる。 Specifically, examples of the oil component include oils and fats such as olive oil, camellia oil, macadamia nut oil and avocado oil; waxes such as carnauba wax, candelilla wax, jojoba oil, beeswax and lanolin; liquid paraffin, paraffin, petrolatum, Hydrocarbons such as ceresin, microcrystalline wax, squalene, squalane; methylpolysiloxane, methylphenylpolysiloxane, methylcyclopolysiloxane, octamethylcyclotetrasiloxane, octamethylcyclopentasiloxane, decamethylcyclopentasiloxane, methylhydrogenpoly Silicones such as siloxane; isopropyl myristate, 2-octyldodecyl myristate, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, di-2-ethylhexane Neopentyl glycol, glycerol tri-2-ethylhexanoate, 2-octyldodecyl oleate, glycerol triisostearate, glycerol tri-2-ethylhexanoate, 2-octyldodecyl oleate, diisostearyl malate, triisostearic acid Fatty acid esters such as glycerol and 2-ethylhexanoic acid diglyceride; higher alcohols such as cetyl alcohol, stearyl alcohol, isostearyl alcohol, 2-octyldodecanol, and oleyl alcohol; lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid And higher fatty acids such as acid and oleic acid.
界面活性剤としては、ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ヒマシ油、硬化ヒマシ油、及びこれらのアルキレンオキシド付加物、ポリグリセリン脂肪酸エステル、ポリオキシアルキレンアルキルエーテル、ポリオキシアルキレン脂肪酸エステル、ポリオキシアルキレンアルキルフェノール、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレンアルキルフェニルホルムアルデヒド縮合物、ポリオキシエチレンステロール及びその誘導体、ポリオキシエチレンラノリン及びその誘導体、ポリオキシエチレンミツロウ誘導体、シュガーエステル類等の非イオン界面活性剤;高級脂肪酸石鹸、アルキル硫酸エステル塩、アルキルリン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、アルキルエーテルリン酸エステル、アルキルエーテルカルボン酸塩、アシルメチルタウリン塩、N−アシル−N−メチル−β−アラニン塩、N−アシルグリシン塩、N−アシルグルタミン酸塩、ポリオキシエチレンアルキルカルボン酸塩、アルキルフェニルエーテルスルホン酸塩、アルキルスルホコハク酸及びその塩、N−アシルサルコシン及びその塩、ポリオキシエチレンヤシ油脂肪酸モノエタノールアミド硫酸塩等の陰イオン界面活性剤;アルキルアミン塩、脂肪酸アミドアミン塩、エステル含有3級アミン塩等のアミン塩、モノアルキル型4級アンモニウム塩、ジアルキル型4級アンモニウム塩、トリアルキル型4級アンモニウム塩、ベンザルコニウム型4級アンモニウム塩等のアルキル4級アンモニウム塩、アルキルピリジニウム塩等の環式4級アンモニウム塩、塩化ベンゼエトニウム等の陽イオン界面活性剤;アルキルグリシン塩、カルボキシメチルグリシン塩、N−アシルアミノエチル−N−2−ヒドロキシエチルグリシン塩等のグリシン型両性界面活性剤、アルキルアミノプロピオン酸塩、アルキルイミノジプロピオン酸塩等のアミノプロピオン酸型両性界面活性剤、アルキルジメチルアミノ酢酸ベタイン、脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン等のアミノ酢酸ベタイン型両性界面活性剤、アルキルヒドロキシスルホベタイン等のスルホベタイン型両性界面活性剤等の両性界面活性剤を例示することができる。 Surfactants include sorbitan fatty acid ester, glycerin fatty acid ester, castor oil, hydrogenated castor oil, and alkylene oxide adducts thereof, polyglycerin fatty acid ester, polyoxyalkylene alkyl ether, polyoxyalkylene fatty acid ester, polyoxyalkylene alkylphenol. Nonionic surfactants such as polyoxyethylene sorbite fatty acid ester, polyoxyethylene alkylphenyl formaldehyde condensate, polyoxyethylene sterol and derivatives thereof, polyoxyethylene lanolin and derivatives thereof, polyoxyethylene beeswax derivatives and sugar esters; Higher fatty acid soap, alkyl sulfate ester salt, alkyl phosphate, polyoxyethylene alkyl ether sulfate, polyoxyethylene alkyl Phenyl ether sulfate, alkyl ether phosphate, alkyl ether carboxylate, acylmethyl taurate, N-acyl-N-methyl-β-alanine, N-acyl glycine, N-acyl glutamate, polyoxyethylene Anionic surfactants such as alkyl carboxylates, alkyl phenyl ether sulfonates, alkyl sulfosuccinic acids and salts thereof, N-acyl sarcosine and salts thereof, polyoxyethylene coconut oil fatty acid monoethanolamide sulfate; alkylamine salts; Alkyl 4 such as fatty acid amide amine salt, amine salt such as ester-containing tertiary amine salt, monoalkyl type quaternary ammonium salt, dialkyl type quaternary ammonium salt, trialkyl type quaternary ammonium salt, benzalkonium type quaternary ammonium salt Grade ammonium salt Cyclic quaternary ammonium salts such as alkylpyridinium salts, cationic surfactants such as benzethonium chloride; glycine types such as alkylglycine salts, carboxymethylglycine salts, N-acylaminoethyl-N-2-hydroxyethylglycine salts Amphoteric surfactants, aminopropionic acid type amphoteric surfactants such as alkylaminopropionate and alkyliminodipropionate, aminoacetic acid betaine type amphoteric surfactants such as alkyldimethylaminoacetic acid betaine and fatty acid amidopropyldimethylaminoacetic acid betaine And amphoteric surfactants such as sulfobetaine-type amphoteric surfactants such as agents and alkylhydroxysulfobetaines.
アルコール類としては、例えば、エタノール、イソプロパノール、ブタノール等の低級アルコール;1,3−ブタンジオール,グリセリン、ポリグリセリン、エチレングリコール、ポリエチレングリコール、ポリプロピレングリコール等の多価アルコール類;ソルビトール、マンニトール、グルコース、ショ糖、キシリトール、ラクトース、トレハロース等の糖類;コレステロール、フィトステロール等のステロール類を挙げることができる。 Examples of alcohols include lower alcohols such as ethanol, isopropanol, and butanol; polyhydric alcohols such as 1,3-butanediol, glycerin, polyglycerin, ethylene glycol, polyethylene glycol, and polypropylene glycol; sorbitol, mannitol, glucose, Examples thereof include saccharides such as sucrose, xylitol, lactose and trehalose; and sterols such as cholesterol and phytosterol.
増粘性高分子としては、例えば、ベントナイト、スメクタイトの他、バイデライト系、ノントロナイト系、サポナイト系、ヘクトライト系、ソーコナイト系、スチーブンサイト系等の粘度鉱物;カラギーナン、グアーガム、キサンタンガム、アラビアガム、カラヤガム、トラガントガム、デキストラン、アミロース、アミロペクチン、アガロース、プルラン、コンドロイチン硫酸、ペクチン酸ナトリウム、アルギン酸、メチルセルロース、エチルセルロース、カルボキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース等を例示することができる。 As the thickening polymer, for example, bentonite, smectite, beidellite-based, nontronite-based, saponite-based, hectorite-based, soconite-based, stevensite-based viscous minerals; carrageenan, guar gum, xanthan gum, gum arabic, Examples include karaya gum, tragacanth gum, dextran, amylose, amylopectin, agarose, pullulan, chondroitin sulfate, sodium pectate, alginic acid, methylcellulose, ethylcellulose, carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and the like.
紫外線吸収剤としては、例えば、パラアミノ安息香酸、パラアミノ安息香酸モノグリセリンエステル等の安息香酸系紫外線吸収剤;アントラニル酸メチル、ホモメンチル−N−アセチルアントラニレート等のアントラニル酸系紫外線吸収剤;サリチル酸メチル等のサリチル酸系紫外線吸収剤;パラメトキシケイ皮酸オクチル、エチル−4−イソプロピルシンナメート等のケイ皮酸系紫外線吸収剤;2,4−ジヒドロキシベンゾフェノン等のベンゾフェノン系紫外線吸収剤;アミルサリシレート、メンチルサリシレート、ベンジルサリシレート等のサリチル酸系紫外線吸収剤;ウロカニン酸、ウロカニン酸エチル等のウロカニン酸系紫外線吸収剤等が挙げられる。 Examples of the ultraviolet absorber include benzoic acid-based ultraviolet absorbers such as paraaminobenzoic acid and paraaminobenzoic acid monoglycerin ester; anthranilic acid-based ultraviolet absorbers such as methyl anthranilate and homomenthyl-N-acetylanthranilate; methyl salicylate Salicylic acid UV absorbers such as octyl paramethoxycinnamate and ethyl-4-isopropylcinnamate; benzophenone UV absorbers such as 2,4-dihydroxybenzophenone; amyl salicylate and menthyl Examples include salicylic acid ultraviolet absorbers such as salicylate and benzyl salicylate; urocanic acid ultraviolet absorbers such as urocanic acid and ethyl urocanate.
保湿剤としては、例えば、エチレングリコール、ポリエチレングリコール、プロピレングリコール、ポリプロピレングリコール、1,3−ブチレングリコール、グリセリン、ポリグリセリン等の多価アルコール類;グルコース、マルトース、マルチトール、スクロール、マンニトール、ソルビトール、キシリトール等の糖類;ポリオキシエチレンメチルグルコシド、ポリオキシプロピレンメチルグルコシド等の糖誘導体;デキストリン、コンドロイチン硫酸等の多糖類;グリシン、アラニン、セリン、アルギニン、グルタミン酸等のアミノ酸類;クエン酸ナトリウム、乳酸ナトリウム、リンゴ酸ナトリウム等の有機酸塩等が挙げられる。 Examples of the humectant include polyhydric alcohols such as ethylene glycol, polyethylene glycol, propylene glycol, polypropylene glycol, 1,3-butylene glycol, glycerin and polyglycerin; glucose, maltose, maltitol, scroll, mannitol, sorbitol, Sugars such as xylitol; sugar derivatives such as polyoxyethylene methyl glucoside and polyoxypropylene methyl glucoside; polysaccharides such as dextrin and chondroitin sulfate; amino acids such as glycine, alanine, serine, arginine and glutamic acid; sodium citrate and sodium lactate And organic acid salts such as sodium malate.
酸化防止剤としては、例えば、α−トコフェロール及びその誘導体、アスコルビン酸及びその誘導体、エリソルビン酸、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、没食子酸エステル類、亜硫酸、重亜硫酸、チオ硫酸、チオ乳酸、チオグリコール酸、L−システイン、N−アセチル−L−システイン等を挙げることができる。 Examples of the antioxidant include α-tocopherol and its derivatives, ascorbic acid and its derivatives, erythorbic acid, dibutylhydroxytoluene, butylhydroxyanisole, gallic acid esters, sulfurous acid, bisulfite, thiosulfuric acid, thiolactic acid, thioglycol An acid, L-cysteine, N-acetyl-L-cysteine, etc. can be mentioned.
金属イオン封鎖剤としては、例えば、エデト酸塩、リン酸、ポリリン酸ナトリウム、メタリン酸ナトリウム、アラニン、シュウ酸ナトリウム、ニトリロ三酢酸、1,2−ジアミノシクロヘキサン−四酢酸、N−オキシエチルエチレンジアミン−三酢酸、エチレングリコールビス−四酢酸、エチレンジアミン−四プロピオン酸、1−ヒドロキシヘキサン−1,1−ジホスホン酸、ホスホノ酢酸、ジエチレントリアミン五酢酸、1,2−シクロヘキサンジアミン四酢酸、エチレンジアミン二酢酸、トリエチレンテトラミン六酢酸等を挙げることができる。 Examples of the sequestering agent include edetate, phosphoric acid, sodium polyphosphate, sodium metaphosphate, alanine, sodium oxalate, nitrilotriacetic acid, 1,2-diaminocyclohexane-tetraacetic acid, N-oxyethylethylenediamine- Triacetic acid, ethylene glycol bis-tetraacetic acid, ethylenediamine-tetrapropionic acid, 1-hydroxyhexane-1,1-diphosphonic acid, phosphonoacetic acid, diethylenetriaminepentaacetic acid, 1,2-cyclohexanediaminetetraacetic acid, ethylenediaminediacetic acid, triethylene Examples thereof include tetramine hexaacetic acid.
本発明の皮膚化粧料は、化粧品や医薬部外品などの化粧料として使用することができる。具体的には、化粧水、乳液、スキンクリーム、美容液、洗顔剤、アフターシェーブローション等に好適に用いることができる。 The skin cosmetics of the present invention can be used as cosmetics such as cosmetics and quasi drugs. Specifically, it can be suitably used for lotion, milky lotion, skin cream, cosmetic liquid, facial cleanser, after-shave lotion and the like.
以下、本発明を実施例に基づいて更に詳細に説明するが、本発明は、かかる実施例のみに限定されるものではない。尚、含有量は、特記しない限り「重量%」を表す。また、POEは、ポリオキシエチレンの略であり、POEの付加モル数は括弧内に表記する。 EXAMPLES Hereinafter, although this invention is demonstrated further in detail based on an Example, this invention is not limited only to this Example. The content represents “% by weight” unless otherwise specified. POE is an abbreviation for polyoxyethylene, and the added mole number of POE is shown in parentheses.
〔試料の調製〕
ヒアルロン酸オリゴ糖は、国際公開第2002/4471号パンフレットの方法に準じて調製した。すなわち、ヒアルロン酸ナトリウム10gを100mMリン酸緩衝液(pH5.3)450mLに加えて攪拌し、ヒアルロニダーゼ80mgを添加して37℃の恒温下で24時間酵素分解した。得られた反応液を遠心分離機(10000rpm,30分)にて上清を回収し、強塩基性イオン交換樹脂I型(商品名Dowex1x2、ダウケミカル社製)を充填したカラムにて、塩化ナトリウム水溶液を溶出液として分画した。目的の画分を脱塩処理後、凍結乾燥してヒアルロン酸オリゴ糖1.6gを得た。得られたヒアルロン酸オリゴ糖をゲルろ過クロマトグラフィーにて分析した結果、210nmの相対的なピーク面積から、6糖以下のヒアルロン酸オリゴ糖として純度約80%,4糖以下のヒアルロン酸オリゴ糖として純度約60%であった。
上記で得られたヒアルロン酸オリゴ糖を用い、表1に記した組成に従い、実施例及び比較例のローションをそれぞれ定法により調製し、下記評価に供した。尚、各表中の配合量は、「重量%」である。
(Sample preparation)
Hyaluronic acid oligosaccharide was prepared according to the method of International Publication No. 2002/4471 pamphlet. That is, 10 g of sodium hyaluronate was added to 450 mL of 100 mM phosphate buffer (pH 5.3), stirred, 80 mg of hyaluronidase was added, and enzymatic degradation was performed at a constant temperature of 37 ° C. for 24 hours. The supernatant of the obtained reaction solution was collected with a centrifuge (10000 rpm, 30 minutes), and sodium chloride was added to a column packed with strongly basic ion exchange resin type I (trade name Dowex 1 × 2, manufactured by Dow Chemical Co.). The aqueous solution was fractionated as an eluent. The desired fraction was desalted and lyophilized to obtain 1.6 g of hyaluronic acid oligosaccharide. As a result of analyzing the obtained hyaluronic acid oligosaccharide by gel filtration chromatography, as a hyaluronic acid oligosaccharide having a purity of about 80% as a hyaluronic acid oligosaccharide of 6 sugars or less and a hyaluronic acid oligosaccharide of 4 sugars or less from a relative peak area of 210 nm. The purity was about 60%.
Using the hyaluronic acid oligosaccharide obtained above, according to the composition described in Table 1, lotions of Examples and Comparative Examples were respectively prepared by conventional methods and subjected to the following evaluation. In addition, the compounding quantity in each table | surface is "weight%."
〔試験例1;荒肌改善効果試験〕
実施例及び比較例の各試料の約1mLづつを、朝晩2回、荒れ肌に悩む被験者10名に4週間連続して塗布し、荒肌の改善効果を下記評価基準に基づき、肉眼で評価した。尚、評価結果は、各被験者の平均の値を採用した。結果を表1に併記する。
[Test Example 1; rough skin improvement effect test]
About 1 mL of each sample of Examples and Comparative Examples was applied twice a morning and evening to 10 subjects suffering from rough skin continuously for 4 weeks, and the effect of improving rough skin was evaluated with the naked eye based on the following evaluation criteria. In addition, the average value of each test subject was employ | adopted for the evaluation result. The results are also shown in Table 1.
<評価基準>
◎;全く落屑がなく正常な肌に改善された。
○;ほぼ正常な肌に改善された。
△;やや改善された。
×;明らかに落屑があり全く改善されていない。
<Evaluation criteria>
A: There was no desquamation, and the skin was improved.
○: Improved to almost normal skin.
Δ: Slightly improved.
X: Clearly there is desquamation and it has not been improved at all.
〔試験例2;皮膚保湿性効果試験〕
実施例及び比較例の各試料の皮膚保湿性効果について、10名の被験者により評価した。すなわち、各被験者の顔面を、洗顔料を用いて温水で洗浄し、温度20℃,湿度50%の恒温恒湿室にて15分間安静にさせ、額部を対象として皮膚水分量を皮表角層水分量測定装置(SKICON−200EX型;アイ・ビイ・エス社製)にて測定した。測定は、皮膚水分量の初期値を測定し、30分後に実施例及び比較例の各試料を塗布し、塗布後30分後,3時間後,6時間後の各皮膚水分量を測定し、その平均値を採用した。結果を図1に示す。
[Test Example 2: Skin moisturizing effect test]
The skin moisturizing effect of each sample of Examples and Comparative Examples was evaluated by 10 subjects. That is, the face of each subject was washed with warm water using a facial cleanser and allowed to rest in a constant temperature and humidity chamber at a temperature of 20 ° C. and a humidity of 50% for 15 minutes. It measured with the water | moisture content amount measuring apparatus (SKICON-200EX type; made by IB S). The measurement is to measure the initial value of the moisture content of the skin, and after 30 minutes, the samples of Examples and Comparative Examples are applied, and after 30 minutes, 3 hours and 6 hours after application, the moisture content of each skin is measured. The average value was adopted. The results are shown in FIG.
〔試験例3;皮膚バリア回復効果試験〕
実施例及び比較例の各試料の皮膚バリア回復効果について、10名の被験者により評価した。すなわち、被験者の前腕内側部の経皮水分蒸散量(TEWL)を皮膚水分蒸散量測定装置(TEWAMETER TM210型;Courage+Khazaka electronic社製)にて測定した。このTEWL値(T1)を100%とした。次に、前腕内側部をテープストリッピングして皮膚バリアを破壊し、同様にTEWLを測定した。このTEWL値(T0)を0%とした。
[Test Example 3: Skin barrier recovery effect test]
The skin barrier recovery effect of each sample of Examples and Comparative Examples was evaluated by 10 subjects. That is, the percutaneous moisture transpiration (TEWL) of the inner side of the forearm of the test subject was measured with a skin moisture transpiration measuring device (TEWAMETER TM210 type; manufactured by Curage + Khazaka electronic). The TEWL value (T 1 ) was 100%. Next, the skin barrier was broken by tape stripping the inner part of the forearm, and TEWL was measured in the same manner. The TEWL value (T 0 ) was set to 0%.
その後、実施例及び比較例の各試料をテープストリッピングした部分に1日1回入浴後に塗布し、14日間続けたのちTEWLを測定した。このTEWL値(T2)を百分率に換算し、TEWLの回復率を下記式から求め、その平均値を採用した。結果を表1に併記する。
TEWL回復率(%)=[(T2−T0)/(T1−T0)]×100
Thereafter, each sample of Examples and Comparative Examples was applied to the tape stripped part once a day after bathing, and continued for 14 days, and then TEWL was measured. The TEWL value (T 2 ) was converted to a percentage, the TEWL recovery rate was determined from the following formula, and the average value was adopted. The results are also shown in Table 1.
TEWL recovery rate (%) = [(T 2 −T 0 ) / (T 1 −T 0 )] × 100
表1及び図1の結果から、本発明の皮膚化粧料は、皮膚の水分保持機能を亢進して荒肌並びに角質層を改善し、皮膚を健常な状態に保持して皮膚老化防止効果を奏することが分かる。 From the results shown in Table 1 and FIG. 1, the skin cosmetic of the present invention improves the moisture retention function of the skin, improves rough skin and the stratum corneum, and keeps the skin in a healthy state, thereby exhibiting an effect of preventing skin aging. I understand that.
以下、本発明に係る皮膚化粧料の処方例を示す。尚、配合量は重量%である。 Hereinafter, formulation examples of skin cosmetics according to the present invention will be shown. In addition, a compounding quantity is weight%.
(配合例1;エモリエントローション)
ワセリン 2.0
スクワラン 5.0
セスキオレイン酸ソルビタン 0.8
ポリオキシエチレンオレイルエーテル(20E.O.) 1.5
1,2−オクタンジオール 0.1
コラーゲンペプチド(平均分子量1500) 1.0
ヒアルロン酸オリゴ糖(2〜4糖) 1.0
カルボキシビニルポリマー 0.16
水酸化カリウム 0.1
メチルパラベン 0.3
香料 適 量
紫外線吸収剤 適 量
精製水 残 分
合 計 100.0
(Formulation example 1; emollient lotion)
Vaseline 2.0
Squalane 5.0
Sorbitan sesquioleate 0.8
Polyoxyethylene oleyl ether (20E.O.) 1.5
1,2-octanediol 0.1
Collagen peptide (average molecular weight 1500) 1.0
Hyaluronic acid oligosaccharide (2-4 sugars) 1.0
Carboxyvinyl polymer 0.16
Potassium hydroxide 0.1
Methylparaben 0.3
Perfume appropriate amount UV absorber appropriate amount
Purified water residue Total 100.0
(配合例2;エモリエントローション)
流動パラフィン 15.0
ミツロウ 2.0
ラノリン 1.5
セスキオレイン酸ソルビタン 2.5
ポリオキシエチレンソルビタンモノオレイン酸エステル 1.0
1,2−ヘキサンジオール 1.0
1,2−オクタンジオール 0.05
コラーゲンペプチド(平均分子量1500) 0.5
ヒアルロン酸オリゴ糖(2〜4糖) 0.3
プロピレングリコール 3.0
香料 適 量
紫外線吸収剤 適 量
精製水 残 分
合 計 100.0
(Formulation example 2; emollient lotion)
Liquid paraffin 15.0
Beeswax 2.0
Lanolin 1.5
Sorbitan sesquioleate 2.5
Polyoxyethylene sorbitan monooleate 1.0
1,2-hexanediol 1.0
1,2-octanediol 0.05
Collagen peptide (average molecular weight 1500) 0.5
Hyaluronic acid oligosaccharide (2-4 sugars) 0.3
Propylene glycol 3.0
Perfume appropriate amount UV absorber appropriate amount
Purified water residue Total 100.0
(配合例3;エモリエントクリーム)
ステアリルアルコール 5.0
ステアリン酸 2.0
ワセリン 5.0
スクワラン 5.0
トリ−2−エチルヘキサン酸グリセリル 1.0
ホホバ油 1.0
オリーブ油 1.0
ジプロピレングリコール 4.0
1,2−ペンタンジオール 3.0
1,2−オクタンジオール 0.05
コラーゲンペプチド(平均分子量3000) 1.0
ヒアルロン酸オリゴ糖(4糖) 0.1
プロピレングリコールモノステアリン酸エステル 2.5
ポリオキシエチレンセチルエーテル 3.0
トリエタノールアミン 1.0
メチルパラベン 0.15
プロピルパラベン 0.1
香料 適 量
酸化防止剤 適 量
精製水 残 分
合 計 100.0
(Formulation example 3; emollient cream)
Stearyl alcohol 5.0
Stearic acid 2.0
Vaseline 5.0
Squalane 5.0
Glyceryl tri-2-ethylhexanoate 1.0
Jojoba oil 1.0
Olive oil 1.0
Dipropylene glycol 4.0
1,2-pentanediol 3.0
1,2-octanediol 0.05
Collagen peptide (average molecular weight 3000) 1.0
Hyaluronic acid oligosaccharide (tetrasaccharide) 0.1
Propylene glycol monostearate 2.5
Polyoxyethylene cetyl ether 3.0
Triethanolamine 1.0
Methylparaben 0.15
Propylparaben 0.1
Perfume appropriate amount Antioxidant appropriate amount
Purified water residue Total 100.0
(配合例4;マッサージクリーム)
固形パラフィン 5.0
ミツロウ 8.0
ワセリン 8.0
流動パラフィン 30.0
トリ−2−エチルヘキサン酸グリセリル 1.0
ホホバ油 1.0
オリーブ油 1.0
1,2−オクタンジオール 0.15
コラーゲンペプチド(平均分子量3000) 2.0
ヒアルロン酸オリゴ糖(平均分子量2〜4糖) 0.1
ポリオキシエチレンソルビタンモノラウリン酸エステル 2.0
モノステアリン酸グリセリル 1.6
メチルパラベン 0.15
プロピルパラベン 0.15
香料 適 量
酸化防止剤 適 量
精製水 残 分
合 計 100.0
(Formulation example 4: massage cream)
Solid paraffin 5.0
Beeswah 8.0
Vaseline 8.0
Liquid paraffin 30.0
Glyceryl tri-2-ethylhexanoate 1.0
Jojoba oil 1.0
Olive oil 1.0
1,2-octanediol 0.15
Collagen peptide (average molecular weight 3000) 2.0
Hyaluronic acid oligosaccharide (average molecular weight 2-4 sugar) 0.1
Polyoxyethylene sorbitan monolaurate 2.0
Glyceryl monostearate 1.6
Methylparaben 0.15
Propylparaben 0.15
Perfume appropriate amount Antioxidant appropriate amount
Purified water residue Total 100.0
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007301421A JP2008163006A (en) | 2006-12-04 | 2007-11-21 | Skin cosmetic |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006327594 | 2006-12-04 | ||
| JP2007301421A JP2008163006A (en) | 2006-12-04 | 2007-11-21 | Skin cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2008163006A true JP2008163006A (en) | 2008-07-17 |
Family
ID=39692956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007301421A Pending JP2008163006A (en) | 2006-12-04 | 2007-11-21 | Skin cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008163006A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010054859A1 (en) * | 2008-11-17 | 2010-05-20 | Uterstaedt Andrea | Antiwrinkle implement |
| EP2206483A1 (en) * | 2009-01-12 | 2010-07-14 | Andrea Uterstädt | Anti-wrinkle pin |
| JP2011057607A (en) * | 2009-09-09 | 2011-03-24 | Toshitsu Kagaku Kenkyusho:Kk | Composition containing hyaluronic acid and hyaluronic acid oligo-saccharide |
| JP2014080374A (en) * | 2012-10-12 | 2014-05-08 | Yoshihiro Tokutome | Composition for iontophoresis |
| JP2015124194A (en) * | 2013-12-26 | 2015-07-06 | 日油株式会社 | External preparation for skin |
| JP2016098222A (en) * | 2014-11-26 | 2016-05-30 | 小林製薬株式会社 | Composition for external use |
| JP2016098223A (en) * | 2014-11-26 | 2016-05-30 | 小林製薬株式会社 | External composition |
| JP2017066060A (en) * | 2015-09-29 | 2017-04-06 | 小林製薬株式会社 | External composition |
| WO2021173160A1 (en) * | 2020-02-28 | 2021-09-02 | Chanda Zaveri | Hair growth and scalp preparations |
-
2007
- 2007-11-21 JP JP2007301421A patent/JP2008163006A/en active Pending
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010054859A1 (en) * | 2008-11-17 | 2010-05-20 | Uterstaedt Andrea | Antiwrinkle implement |
| EP2206483A1 (en) * | 2009-01-12 | 2010-07-14 | Andrea Uterstädt | Anti-wrinkle pin |
| JP2011057607A (en) * | 2009-09-09 | 2011-03-24 | Toshitsu Kagaku Kenkyusho:Kk | Composition containing hyaluronic acid and hyaluronic acid oligo-saccharide |
| JP2014080374A (en) * | 2012-10-12 | 2014-05-08 | Yoshihiro Tokutome | Composition for iontophoresis |
| JP2015124194A (en) * | 2013-12-26 | 2015-07-06 | 日油株式会社 | External preparation for skin |
| JP2016098222A (en) * | 2014-11-26 | 2016-05-30 | 小林製薬株式会社 | Composition for external use |
| JP2016098223A (en) * | 2014-11-26 | 2016-05-30 | 小林製薬株式会社 | External composition |
| WO2016084709A1 (en) * | 2014-11-26 | 2016-06-02 | 小林製薬株式会社 | Composition for external use |
| WO2016084708A1 (en) * | 2014-11-26 | 2016-06-02 | 小林製薬株式会社 | Composition for external use |
| JP2017066060A (en) * | 2015-09-29 | 2017-04-06 | 小林製薬株式会社 | External composition |
| WO2021173160A1 (en) * | 2020-02-28 | 2021-09-02 | Chanda Zaveri | Hair growth and scalp preparations |
| US20230301893A1 (en) * | 2020-02-28 | 2023-09-28 | Meng Teng Lim | Hair Growth and Scalp Preparations |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008163006A (en) | Skin cosmetic | |
| JP6218380B2 (en) | External composition for improving skin quality | |
| KR100929264B1 (en) | External skin preparation | |
| WO2009116450A1 (en) | Elastase activity inhibitor | |
| JP3302525B2 (en) | External preparation for skin | |
| JP2005306831A (en) | Skin preparation | |
| JP2004323401A (en) | Skin care preparation for external use | |
| JPH11193207A (en) | Preparation for external use for skin | |
| TW201517912A (en) | Crosslinked product of carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof, and method for producing same | |
| JP2010013378A (en) | External preparation composition for skin | |
| JP5522819B2 (en) | Antibacterial composition and external preparation for skin | |
| JP5734536B1 (en) | Carboxymethyl group-containing modified hyaluronic acid and / or a salt thereof and a method for producing the same | |
| JP2003267856A (en) | Wrinkle preventing cosmetic | |
| JP5743379B2 (en) | Skin cosmetics | |
| JPH09263511A (en) | External preparation for skin | |
| ITVA20110009A1 (en) | COSMETIC COMPOSITION FOR THE SKIN | |
| JP4058399B2 (en) | Cosmetics for exfoliating | |
| JPH09176030A (en) | Sebum secretagogue | |
| JPH11193212A (en) | Skin preparation for external use for keeping and enhancing skin ph buffering ability | |
| JP5527917B2 (en) | Arginase activity promoter and skin external preparation containing the same | |
| JP4726497B2 (en) | Cosmetics | |
| JP2004107238A (en) | Dry skin improvement kit | |
| JP2003063959A (en) | Aging-preventing agent | |
| JP2000119154A (en) | Skin lotion | |
| JP2003238383A (en) | External preparation for skin |